Answers are grounded in this paper and cite their sources.
Our data strongly indicate that a crosstalk between STAT1, DTX3L and ARTD-like mono-ADP-ribosyltransferases mediates proliferation and survival of mPCa cells. The present study further suggests that the combined targeted inhibition of STAT1, ARTD8, ARTD9 and/or DTX3L could increase the efficacy of chemotherapy or radiation treatment in prostate and other high-risk tumor types with an increased STAT1 signaling.
No takes yet. Share an insight, caveat, or question.
Bachmann et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: